Status:
COMPLETED
Preliminary Study 1 to Test the Effects of Ambulatory Voice Biofeedback
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Vocal Fold Nodules
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This first study will enroll 3 groups of patients with vocal fold nodules that will receive different schedules of ambulatory voice biofeedback (100% frequency feedback, 25% frequency feedback, summar...
Detailed Description
We will conduct this study (based on principles of motor learning) using novel smartphone-based ambulatory voice biofeedback systems aimed at improving the carryover of newly established vocal behavio...
Eligibility Criteria
Inclusion
- Patients with vocal fold nodules
Exclusion
- Non-English speakers are excluded because prompts on the smartphone app are only available in English
Key Trial Info
Start Date :
September 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03416829
Start Date
September 27 2017
End Date
June 30 2022
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital - Center for Laryngeal Surgery and Voice Rehabilitation
Boston, Massachusetts, United States, 02114